UNSPSC 51263400: Adrenergic blocking agent pyrimidine nucleosides and quaternary ammonium compounds and secologanin tryptamine alkaloids and spiro compounds and sulfonamides

This classification denotes Adrenergic blocking agent drugs made from or based in part on pyrimidine nucleosides, quaternary ammonium compounds, secologanin tryptamine alkaloids, spiro compounds, or sulfonamides

UNSPSC 51263400, a Class code for adrenergic blocking agents and related pharmaceutical compounds, shows minimal recent alignment with actual state and local procurement activity. The single recent opportunity on record — Seminole County, Florida's IFB60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the code's nominal pharmaceutical taxonomy. The opportunity seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must submit bids electronically, include all shipping and delivery costs in their proposals, comply with drug-free workplace certification and E-Verify requirements, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract term is two years with a one-year renewal option, subject to a three-month probationary period during which Seminole County may terminate with or without cause. Potential FEMA funding introduces compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

This code shows limited recent state and local procurement activity. The single posted opportunity originates from Seminole County, a Florida county government. The mismatch between the code's pharmaceutical scope and the naloxone and drug-deactivation equipment actually being solicited suggests either miscoding by the issuing body or poor alignment between UNSPSC taxonomy and the goods being purchased. The IFB closed on July 26, 2023, with a question deadline of July 21, 2023. Without additional recent opportunities under this code, activity appears sparse; business development professionals should verify whether naloxone procurement in Florida and elsewhere is routinely tagged to this code, or whether activity has shifted to alternative UNSPSC families better suited to medical countermeasures and emergency-response consumables.